106 related articles for article (PubMed ID: 18561174)
1. Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation.
Imamura M; Imai C; Takachi T; Nemoto T; Tanaka A; Uchiyama M
Pediatr Blood Cancer; 2008 Oct; 51(4):569. PubMed ID: 18561174
[No Abstract] [Full Text] [Related]
2. RAS pathway mutations in juvenile myelomonocytic leukemia.
Emanuel PD
Acta Haematol; 2008; 119(4):207-11. PubMed ID: 18566538
[TBL] [Abstract][Full Text] [Related]
3. Hemophagocytosis associated with leukemia: a striking association with juvenile myelomonocytic leukemia.
Unal S; Cetin M; Kutlay NY; Elmas SA; Gumruk F; Tukun A; Tuncer M; Gurgey A
Ann Hematol; 2010 Apr; 89(4):359-64. PubMed ID: 19798502
[TBL] [Abstract][Full Text] [Related]
4. Aggressive transformation of juvenile myelomonocytic leukemia associated with duplication of oncogenic KRAS due to acquired uniparental disomy.
Kato M; Yasui N; Seki M; Kishimoto H; Sato-Otsubo A; Hasegawa D; Kiyokawa N; Hanada R; Ogawa S; Manabe A; Takita J; Koh K
J Pediatr; 2013 Jun; 162(6):1285-8, 1288.e1. PubMed ID: 23403250
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
Matsuda K; Sakashita K; Taira C; Tanaka-Yanagisawa M; Yanagisawa R; Shiohara M; Kanegane H; Hasegawa D; Kawasaki K; Endo M; Yajima S; Sasaki S; Kato K; Koike K; Kikuchi A; Ogawa A; Watanabe A; Sotomatsu M; Nonoyama S; Koike K
Br J Haematol; 2010 Feb; 148(4):593-9. PubMed ID: 19874312
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation.
Matsuda K; Nakazawa Y; Sakashita K; Shiohara M; Yamauchi K; Koike K
Haematologica; 2007 Nov; 92(11):1576-8. PubMed ID: 18024411
[TBL] [Abstract][Full Text] [Related]
7. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
[No Abstract] [Full Text] [Related]
8. Juvenile myelomonocytic leukaemia: a case series.
Azma RZ; Zarina AL; Hamidah A; Jamal R; Sharifah NA; Ainoon O; Hamidah NH
Malays J Pathol; 2009 Dec; 31(2):121-8. PubMed ID: 20514855
[TBL] [Abstract][Full Text] [Related]
9. How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia.
Flotho C; Kratz CP; Niemeyer CM
Haematologica; 2007 Nov; 92(11):1441-6. PubMed ID: 18024390
[No Abstract] [Full Text] [Related]
10. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
[No Abstract] [Full Text] [Related]
11. Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.
Jakovljević G; Kardum-Skelin I; Rogosić S; Nakić M
Coll Antropol; 2010 Mar; 34(1):251-4. PubMed ID: 20432758
[TBL] [Abstract][Full Text] [Related]
12. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
Tanaka M; Takahashi Y; Xu Y; Yoshida N; Yoshimi A; Villalobos IB; Hama A; Nishio N; Hidaka H; Wang Y; Yagasaki H; Kojima S
Leuk Res; 2008 Jul; 32(7):1036-42. PubMed ID: 18164384
[TBL] [Abstract][Full Text] [Related]
13. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
Maschan M; Bobrynina V; Khachatryan L; Kalinina I; Solopova G; Avdonin P; Nasedkina T; Novichkova G; Maschan A
Pediatr Blood Cancer; 2014 Oct; 61(10):1871-3. PubMed ID: 24590757
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
Koike K; Matsuda K
Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia.
Yoshida N; Yagasaki H; Takahashi Y; Kudo K; Manabe A; Kojima S
Br J Haematol; 2008 Sep; 142(5):850-1. PubMed ID: 18492118
[No Abstract] [Full Text] [Related]
16. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
Sugimoto Y; Muramatsu H; Makishima H; Prince C; Jankowska AM; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841
[TBL] [Abstract][Full Text] [Related]
17. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Caye A; Strullu M; Guidez F; Cassinat B; Gazal S; Fenneteau O; Lainey E; Nouri K; Nakhaei-Rad S; Dvorsky R; Lachenaud J; Pereira S; Vivent J; Verger E; Vidaud D; Galambrun C; Picard C; Petit A; Contet A; Poirée M; Sirvent N; Méchinaud F; Adjaoud D; Paillard C; Nelken B; Reguerre Y; Bertrand Y; Häussinger D; Dalle JH; Ahmadian MR; Baruchel A; Chomienne C; Cavé H
Nat Genet; 2015 Nov; 47(11):1334-40. PubMed ID: 26457648
[TBL] [Abstract][Full Text] [Related]
18. Lineage-dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia.
Tokuda K; Eguchi-Ishimae M; Iwabuki H; Kawakami S; Tauchi H; Ishii E; Eguchi M
Eur J Haematol; 2015 Feb; 94(2):177-81. PubMed ID: 24766281
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation.
Alsultan A; Khalifah M; Alrabiaah AA
Pediatr Hematol Oncol; 2012 Oct; 29(7):624-6. PubMed ID: 22857389
[No Abstract] [Full Text] [Related]
20. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
[No Abstract] [Full Text] [Related]
[Next] [New Search]